Moderna is focusing on respiratory vaccines to sustain revenue streams amid COVID-19 declines. See more on MRNA stock and its ...

Northwestern filed a lawsuit against Moderna Wednesday alleging the company misused the University’s patented lipid ...

He said: “The UK is leading the way to develop a world-first vaccine for this vomiting bug, starting with this innovative ...

A norovirus vaccine based on the mRNA technology that helped to defeat Covid will be trialled in the UK for the first time, ...

Wes Streeting said the virus places the health service under 'huge strain' every winter and costs taxpayers around ...

It is hoped a study will show the jab is effective against the highly infectious disease which puts the NHS under "huge ...

The new mRNA vaccine from Moderna will enter final stages of testing within the next two weeks, with results so far showing ...

Based in Cambridge, Massachusetts, Moderna, Inc. (MRNA) is a leading biotechnology company that develops messenger RNA (mRNA) ...

Updated COVID-19 vaccines targeting JN.1-lineage omicron variants of the coronavirus are now available in the U.S. for the ...

In one of our recent articles about 10 High Growth Non-Tech Stocks That Are Profitable in 2024, we talked about how the US ...

Roivant's high valuation is justified, with a strong cash position, promising drug pipeline, and strategic partnerships ...

Adrian McRae, a member of West Australia’s Port Hedland Council has doubled down on his praise for Russian democracy in ...